NCT02625246View on ClinicalTrials.gov

Safety and Potential Efficacy of Human Mesenchymal Stem Cells in Non-Cystic Fibrosis Bronchiectasis

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 4, 2016

Primary Completion Date

May 15, 2019

Study Completion Date

May 15, 2019

Conditions
Bronchiectasis
Interventions
BIOLOGICAL

hMSCs

intravenous infusion of bone marrow-derived allogeneic stem cells

Trial Locations (1)

33136

University of Miami Hospitals & Clinics, Miami

All Listed Sponsors
lead

Marilyn Glassberg

OTHER

NCT02625246 - Safety and Potential Efficacy of Human Mesenchymal Stem Cells in Non-Cystic Fibrosis Bronchiectasis | Biotech Hunter | Biotech Hunter